Cutis Marmorata Telangiectatica Congenita Presenting as a Fetal Hemothorax

Area of Science:

• Perinatology
• Fetal Medicine
• Pediatric Cardiology

Background:

• Spontaneous fetal hemothorax is a rare but serious condition requiring timely diagnosis and intervention.
• Prenatal diagnosis and management strategies for fetal hemothorax are not well-established.
• Associated conditions like cutis marmorata telangiectatica congenita (CMTC) and pulmonary lymphangiectasia can complicate management.

Observation:

• A fetus diagnosed with spontaneous hemothorax at 28 weeks gestation underwent two thoracenteses for pleural effusion analysis.
• Recurrence of hemothorax led to mediastinal shift, hydrops, and nonreassuring fetal testing, necessitating delivery at 31 weeks.
• Postnatal evaluation identified cutis marmorata telangiectatica congenita (CMTC) and pulmonary lymphangiectasia.

Findings:

• Fetal thoracentesis can be a viable intervention for managing spontaneous fetal hemothorax.
• Successful management of fetal hemothorax can lead to favorable outcomes even with associated congenital conditions.
• Children with CMTC and pulmonary lymphangiectasia can achieve long-term health without sequelae after appropriate prenatal and postnatal care.

Implications:

• This case highlights the potential for successful fetal intervention in managing spontaneous hemothorax.
• Early diagnosis and management of fetal hemothorax may improve perinatal outcomes.
• Further research is warranted to establish standardized protocols for managing fetal hemothorax and associated conditions.